why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: April 01, 2025

Clinical Trial: A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: RSV Infection

Study Type: INTERVENTIONAL


Official Title: A Non-Randomized, Multiple-Dose, Open-Label, Single Sequence Study to Evaluate the Effect of Concomitant Administration of EDP-323 on the Pharmacokinetics and Safety of Midazolam, Caffeine, and Rosuva

Brief Summary: The primary aim of this study is to assess the effect of EDP-323 on the pharmacokinetics and safety of midazolam, caffeine, and rosuvastatin in healthy adult participants.

Read more